Literature DB >> 87521

Comparison of the small RNAs of polymerase-deficient and polymerase-positive Rous sarcoma virus and another species of avian retrovirus.

R C Sawyer, H Hanafusa.   

Abstract

The small RNAs contained in virions of avian leukosis and sarcoma viruses are a virus-specific subset of the total small RNA population of the host cell. The reverse transcriptase protein must be present in the budding virion for this selection to take place. Virions of the alpha form of the Bryan strain of Rous sarcoma virus, which lack detectable reverse transcriptase, incorporated an unselected population of small RNAs identical to total chicken cell small RNA. Virions of reticuloendotheliosis virus, which contain a reverse transcriptase unrelated to that of the avian leukosis and sarcoma viruses, contained a distinctly different population of small RNAs although both the avian leukosis and sarcoma and the reticuloendotheliosis viruses were grown in chicken cells. Because the primer for avian leukosis and sarcoma virus RNA-dependent DNA synthesis is a host cell tRNA, the differences in reverse transcriptase small RNA selection may help explain the failure of different species of retrovirus to complement for the reverse transcriptase.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87521      PMCID: PMC353245          DOI: 10.1128/JVI.29.3.863-871.1979

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  A primer ribonucleic acid for initiation of in vitro Rous sarcarcoma virus deoxyribonucleic acid synthesis.

Authors:  F Harada; R C Sawyer; J E Dahlberg
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

2.  Phenotypic mixing between reticuloendotheliosis virus and avian sarcoma viruses.

Authors:  P K Vogt; J L Spencer; W Okazaki; R L Witter; L B Crittenden
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

3.  Transcription of DNA from the 70S RNA of Rous sarcoma virus. I. Identification of a specific 4S RNA which serves as primer.

Authors:  J E Dahlberg; R C Sawyer; J M Taylor; A J Faras; W E Levinson; H M Goodman; J M Bishop
Journal:  J Virol       Date:  1974-05       Impact factor: 5.103

4.  Transcription of DNA from the 70S RNA of Rous sarcoma virus. II. Structure of a 4S RNA primer.

Authors:  A J Faras; J E Dahlberg; R C Sawyer; F Harada; J M Taylor; W E Levinson; J M Bishop; H M Goodman
Journal:  J Virol       Date:  1974-05       Impact factor: 5.103

5.  Evidence for 30-40S RNA as precursor of the 60-70S RNA of Rous sarcoma virus.

Authors:  E Canaani; K V Helm; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

6.  Ribonucleic acid components of BAI strain A (myeloblastosis) avian tumor virus.

Authors:  R A Bonar; L Sverak; D P Bolognesi; A J Langlois; D Beard; J W Beard
Journal:  Cancer Res       Date:  1967-06       Impact factor: 12.701

7.  The nucleic acid of the Bryan strain of Rous sarcoma virus: purification of the virus and isolation of the nucleic acid.

Authors:  W S Robinson; A Pitkanen; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1965-07       Impact factor: 11.205

8.  Formation of reticuloendotheliosis virus pseudotypes of Rous sarcoma virus.

Authors:  R C Sawyer; H Hanafusa
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

9.  Lack of serological relationship among DNA polymerases of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken cells.

Authors:  S Mizutani; H M Temin
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

10.  Lack of sequence homology among RNAs of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken endogenous RNA-directed DNA polymerase activity.

Authors:  C Y Kang; H M Temin
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

View more
  23 in total

1.  7SL RNA, but not the 54-kd signal recognition particle protein, is an abundant component of both infectious HIV-1 and minimal virus-like particles.

Authors:  Adewunmi A Onafuwa-Nuga; Alice Telesnitsky; Steven R King
Journal:  RNA       Date:  2006-02-17       Impact factor: 4.942

2.  Polymerase-defective mutant of the Bryan high-titer strain of Rous sarcoma virus.

Authors:  M Sudol; T L Lerner; H Hanafusa
Journal:  Nucleic Acids Res       Date:  1986-03-11       Impact factor: 16.971

Review 3.  Primer tRNAs for reverse transcription.

Authors:  J Mak; L Kleiman
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Reverse transcriptase mediated binding of primer tRNA to the viral genome.

Authors:  A Araya; L Sarih; S Litvak
Journal:  Nucleic Acids Res       Date:  1979-08-24       Impact factor: 16.971

5.  Unusual features of integrated cDNAs generated by infection with genome-free retroviruses.

Authors:  K L Levine; B Steiner; K Johnson; R Aronoff; T J Quinton; M L Linial
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

6.  Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers.

Authors:  J M Whitcomb; B A Ortiz-Conde; S H Hughes
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Polyacrylamide gel mapping of chicken tRNA: comparison of polysome-bound and whole-cell tRNA from normal and avian sarcoma virus-infected chicken embryo fibroblasts.

Authors:  F Reinisch; T Heyman
Journal:  Mol Cell Biol       Date:  1982-10       Impact factor: 4.272

8.  Effect of polymerase mutations on packaging of primer tRNAPro during murine leukemia virus assembly.

Authors:  J G Levin; J G Seidman
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

9.  Reverse transcriptase as the major determinant for selective packaging of tRNA's into Avian sarcoma virus particles.

Authors:  G G Peters; J Hu
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

10.  Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site.

Authors:  B Berkhout; I Schoneveld
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.